These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 32907434)
61. Identification of novel dual-specificity phosphatase 26 inhibitors by a hybrid virtual screening approach based on pharmacophore and molecular docking. Ren JX; Cheng Z; Huang YX; Zhao JF; Guo P; Zou ZM; Xie Y Biomed Pharmacother; 2017 May; 89():376-385. PubMed ID: 28249240 [TBL] [Abstract][Full Text] [Related]
62. Carvedilol serves as a novel CYP1B1 inhibitor, a systematic drug repurposing approach through structure-based virtual screening and experimental verification. Wang Y; He X; Li C; Ma Y; Xue W; Hu B; Wang J; Zhang T; Zhang F Eur J Med Chem; 2020 May; 193():112235. PubMed ID: 32203789 [TBL] [Abstract][Full Text] [Related]
63. Virtual screening of small molecules databases for discovery of novel PARP-1 inhibitors: combination of in silico and in vitro studies. Ekhteiari Salmas R; Unlu A; Bektaş M; Yurtsever M; Mestanoglu M; Durdagi S J Biomol Struct Dyn; 2017 Jul; 35(9):1899-1915. PubMed ID: 27315035 [TBL] [Abstract][Full Text] [Related]
64. Identification of sumoylation inhibitors targeting a predicted pocket in Ubc9. Kumar A; Ito A; Hirohama M; Yoshida M; Zhang KY J Chem Inf Model; 2014 Oct; 54(10):2784-93. PubMed ID: 25191977 [TBL] [Abstract][Full Text] [Related]
65. Virtual Screening Strategy Combined Bayesian Classification Model, Molecular Docking for Acetyl-CoA Carboxylases Inhibitors. Zhou WN; Zhang YM; Qiao X; Pan J; Yin LF; Zhu L; Zhao JN; Lu S; Lu T; Chen YD; Liu HC Curr Comput Aided Drug Des; 2019; 15(3):193-205. PubMed ID: 30411690 [TBL] [Abstract][Full Text] [Related]
66. Structure-Based Discovery and Synthesis of Potential Transketolase Inhibitors. Huo J; Zhao B; Zhang Z; Xing J; Zhang J; Dong J; Fan Z Molecules; 2018 Aug; 23(9):. PubMed ID: 30142874 [TBL] [Abstract][Full Text] [Related]
67. New findings of heparanase in human diseases. Jin H; Cui M; Hu SX Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5999-6004. PubMed ID: 31298354 [TBL] [Abstract][Full Text] [Related]
68. Virtual Screening with Docking Simulations and Biochemical Evaluation of VHY Phosphatase Inhibitors. Park H; Lee HS; Kim SJ Chem Pharm Bull (Tokyo); 2015; 63(10):807-11. PubMed ID: 26423037 [TBL] [Abstract][Full Text] [Related]
69. Discovery of novel DNA methyltransferase 3A inhibitors via structure-based virtual screening and biological assays. Shao Z; Xu P; Xu W; Li L; Liu S; Zhang R; Liu YC; Zhang C; Chen S; Luo C Bioorg Med Chem Lett; 2017 Jan; 27(2):342-346. PubMed ID: 27899265 [TBL] [Abstract][Full Text] [Related]
70. The heparanase/heparan sulfate proteoglycan axis: A potential new therapeutic target in sarcomas. Cassinelli G; Zaffaroni N; Lanzi C Cancer Lett; 2016 Nov; 382(2):245-254. PubMed ID: 27666777 [TBL] [Abstract][Full Text] [Related]
71. Discovery of novel phosphatidylcholine-specific phospholipase C drug-like inhibitors as potential anticancer agents. Eurtivong C; Pilkington LI; van Rensburg M; White RM; Brar HK; Rees S; Paulin EK; Xu CS; Sharma N; Leung IKH; Leung E; Barker D; Reynisson J Eur J Med Chem; 2020 Feb; 187():111919. PubMed ID: 31810783 [TBL] [Abstract][Full Text] [Related]
72. Design, synthesis, and evaluation of heparan sulfate mimicking glycopolymers for inhibiting heparanase activity. Loka RS; Yu F; Sletten ET; Nguyen HM Chem Commun (Camb); 2017 Aug; 53(65):9163-9166. PubMed ID: 28766595 [TBL] [Abstract][Full Text] [Related]
73. Development and NMR validation of minimal pharmacophore hypotheses for the generation of fragment libraries enriched in heparanase inhibitors. Gozalbes R; Mosulén S; Carbajo RJ; Pineda-Lucena A J Comput Aided Mol Des; 2009 Aug; 23(8):555-69. PubMed ID: 19421720 [TBL] [Abstract][Full Text] [Related]
74. Bacterial expression and functional reconstitution of human heparanase. Winkler S; Schweiger D; Wei Z; Rajkovic E; Kungl AJ Carbohydr Res; 2014 May; 389():72-7. PubMed ID: 24656445 [TBL] [Abstract][Full Text] [Related]
76. Synthesis of a pseudo-disaccharide library and its application to the characterisation of the heparanase catalytic site. Vinader V; Haji-Abdullahi MH; Patterson LH; Afarinkia K PLoS One; 2013; 8(11):e82111. PubMed ID: 24260588 [TBL] [Abstract][Full Text] [Related]
77. Pharmacophore based 3D-QSAR modeling, virtual screening and docking for identification of potential inhibitors of β-secretase. Palakurti R; Vadrevu R Comput Biol Chem; 2017 Jun; 68():107-117. PubMed ID: 28288354 [TBL] [Abstract][Full Text] [Related]
78. Identification of a novel selective small-molecule inhibitor of protein arginine methyltransferase 5 (PRMT5) by virtual screening, resynthesis and biological evaluations. Zhu K; Jiang C; Tao H; Liu J; Zhang H; Luo C Bioorg Med Chem Lett; 2018 May; 28(9):1476-1483. PubMed ID: 29628326 [TBL] [Abstract][Full Text] [Related]
79. Synthesis, Molecular Docking and β-Glucuronidase Inhibitory Potential of Indole Base Oxadiazole Derivatives. Anouar EH; Moustapha ME; Taha M; Geesi MH; Farag ZR; Rahim F; Almandil NB; Farooq RK; Nawaz M; Mosaddik A Molecules; 2019 Mar; 24(5):. PubMed ID: 30857263 [TBL] [Abstract][Full Text] [Related]
80. Chemical shift assignments and secondary structure of the surrogate domain for drug discovery studies of human heparanase. Mosulén S; Pineda-Lucena A; Carbajo RJ Biomol NMR Assign; 2015 Apr; 9(1):15-9. PubMed ID: 24395156 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]